K

KeyMed Biosciences Inc
HKEX:2162

Watchlist Manager
KeyMed Biosciences Inc
HKEX:2162
Watchlist
Price: 38.2 HKD -3.29% Market Closed
Market Cap: 10.5B HKD
Have any thoughts about
KeyMed Biosciences Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
KeyMed Biosciences Inc

Wall Street analysts forecast KeyMed Biosciences Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 61.11 HKD with a low forecast of 50.5 HKD and a high forecast of 75.6 HKD.

Lowest
Price Target
50.5 HKD
32% Upside
Average
Price Target
61.11 HKD
60% Upside
Highest
Price Target
75.6 HKD
98% Upside
KeyMed Biosciences Inc Competitors:
Price Targets
377740
BioNote Inc
26% Upside
688278
Xiamen Amoytop Biotech Co Ltd
3% Upside
OCC
Orthocell Ltd
9% Downside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
22% Upside
LGND
Ligand Pharmaceuticals Inc
7% Upside
NIOX
Niox Group PLC
29% Upside
KOD
Kodiak Sciences Inc
31% Downside
358570
GI Innovation Inc
154% Upside

Revenue
Forecast

Revenue Estimate
KeyMed Biosciences Inc

The compound annual growth rate of KeyMed Biosciences Inc's revenue for the next 3 years is 58%.

N/A
Past Growth
58%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
KeyMed Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
29%
Average Beat

Net Income
Forecast

Net Income Estimate
KeyMed Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
23%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KeyMed Biosciences Inc's stock price target?
Price Target
61.11 HKD

According to Wall Street analysts, the average 1-year price target for KeyMed Biosciences Inc is 61.11 HKD with a low forecast of 50.5 HKD and a high forecast of 75.6 HKD.

What is KeyMed Biosciences Inc's Revenue forecast?
Projected CAGR
58%

The compound annual growth rate of KeyMed Biosciences Inc's revenue for the next 3 years is 58%.

Back to Top